513
Pill imprint 513 has been identified as Meloxicam 15 mg.
Meloxicam is used in the treatment of osteoarthritis; rheumatoid arthritis; juvenile rheumatoid arthritis; tendonitis; fibromyalgia (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy.
Meloxicam 15 mg is not subject to the Controlled Substances Act.
See also related documents.
Meloxicam Images
- Imprint:
-
513
- Strength:
- 15 mg
- Color:
- Yellow
- Size:
- 11.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
crospovidone
lactose
lactose monohydrate
magnesium stearate
microcrystalline cellulose
povidone
sodium citrate dihydrate
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Caraco Pharmaceutical Laboratories
- National Drug Code (NDC):
- 57664-0513
| NDC Code | Manufacturer / Repackager |
|---|---|
| 58016-0023 | Southwood Pharmaceuticals Inc (repackager) |
| 66336-0774 | Dispensing Solutions Inc. (repackager) |
| 10544-0390 | Blenheim Pharmacal Inc (repackager) |
| 55289-0376 | PDRX Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Meloxicam resources
Search Again
